Fourpath Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $650K | Buy |
|
|||||
|
2025
Q2 | $614K | Sell |
|
|||||
|
2025
Q1 | $760K | Sell |
|
|||||
|
2024
Q4 | $683K | Sell |
|
|||||
|
2024
Q3 | $790K | Buy |
|
|||||
|
2024
Q2 | $782K | Sell |
|
|||||
|
2024
Q1 | $765K | Sell |
|
|||||
|
2023
Q4 | $775K | Sell |
|
|||||
|
2023
Q3 | $710K | Sell |
|
|||||
|
2023
Q2 | $738K | Sell |
|
|||||
|
2023
Q1 | $671K | Sell |
|
|||||
|
2022
Q4 | $623K | Sell |
|
|||||
|
2022
Q3 | $645K | Sell |
|
|||||
|
2022
Q2 | $795K | Sell |
|
|||||
|
2022
Q1 | $937K | Sell |
|
|||||
|
2021
Q4 | $867K | Buy |
|